Commonly known as "Slim Pen", "Slimming Pen", "Slimming Injection" and "Yi Zhou Tang" and other medicines are out of stock.

(Extracted from the Food and Drug Administration website)

[Reporter Lin Huiqin/Taipei Report] Drugs such as "Yi Zhou Tang" commonly known as "Slim Pen", "Slimming Pen" and "Slimming Injection" are out of stock. One can be bought for 1,000 yuan, and now it has soared to 10,000", the price has increased by 9 to 10 times, resulting in real diabetics not being able to get medicine, and disease control is affected. Health and Welfare Minister Xue Ruiyuan spoke at the Social Welfare and Sanitation Committee of the Legislative Yuan today He said that this is a global shortage. Currently, the Food and Drug Administration is in contact with the manufacturer to see if there is sufficient supply for patients. He also hopes that doctors will pay attention to whether there are alternative drugs when prescribing.

"Shoushou Pen" mainly has 4 drugs, including Eli Lilly's "Yi Zhou Tang", and Novo Nordisk's "Zenxianda", "Yituozan" and "Yituosan". The indications include Type 2 diabetes controls blood sugar, reduces the risk of major adverse cardiovascular events, and can even be used for weight control. As an adjuvant therapy in addition to low-calorie diet and increased physical activity, doctors prescribe drugs and take injections.

Currently, health insurance benefits are limited to diabetes treatment, not weight control.

Please read on...

The principle of "Slim Pen" is mainly related to glucagon-like peptide 1 (GLP-1 for short), which is another choice for blood sugar control in recent years, and can act on the central nervous system, gastrointestinal tract, cardiovascular system and other systems , has a hypoglycemic effect, and can slow down gastric emptying, inhibit inappropriate postprandial glucagon release and reduce food intake to achieve weight control effects.

In response to the shortage of "Slim Pen", Xue Ruiyuan explained that this is a global shortage, because the indications include weight loss items, which has caused weight loss people to flock to it, making the drugs that were originally provided for diabetic patients in short supply. Currently, the Food and Drug Administration is following up Contact the manufacturer to see if the supply is sufficient for patients. I also hope that when the doctor writes a prescription, he can consider whether there is an alternative drug when this drug is in short supply, or pay attention to whether this drug must be used for weight loss.